These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 769025)

  • 21. Clinical relevance of thiothixene plasma levels.
    Mavroidis ML; Kanter DR; Hirschowitz J; Garver DL
    J Clin Psychopharmacol; 1984 Jun; 4(3):155-7. PubMed ID: 6736276
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Double-blind comparison of thiothixene and protriptyline in psychotic depression.
    Kiev A
    Dis Nerv Syst; 1972 Dec; 33(12):811-6. PubMed ID: 4668973
    [No Abstract]   [Full Text] [Related]  

  • 23. Trazodone in the treatment of organic brain syndromes, with special reference to psychogeriatrics.
    Nair NP; Ban TA; Hontela S; Clarke R
    Curr Ther Res Clin Exp; 1973 Oct; 15(10):769-75. PubMed ID: 4201974
    [No Abstract]   [Full Text] [Related]  

  • 24. Loxapine succinate: a controlled double-blind study in schizophrenia.
    Charalampous KD; Freemesser GF; Malev J; Ford K
    Curr Ther Res Clin Exp; 1974 Aug; 16(8):829-37. PubMed ID: 4217251
    [No Abstract]   [Full Text] [Related]  

  • 25. Penfluridol and thiothixene. Dosage, plasma levels and changes in psychopathology.
    Jacobsson L; von Knorring L; Mattsson B; Mjörndal T; Oreland L; Perris C; Rapp W; Edenius B; Kettner B; Magnusson KE; Villemoes P
    Int Pharmacopsychiatry; 1976; 11(4):206-14. PubMed ID: 795779
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical experience with molindone hydrochloride in geriatric patients.
    Peper M
    J Clin Psychiatry; 1985 Aug; 46(8 Pt 2):26-9. PubMed ID: 3894339
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical evaluation of thiothixene in acute newly admitted schizophrenic patients.
    Ngui PW; Teo SH
    Singapore Med J; 1971 Aug; 12(4):227-32. PubMed ID: 5129906
    [No Abstract]   [Full Text] [Related]  

  • 28. A double-blind comparison of the effects of haloperidol and cis(Z)-clopenthixol in senile dementia.
    Götestam KG; Ljunghall S; Olsson B
    Acta Psychiatr Scand Suppl; 1981; 294():46-53. PubMed ID: 7041519
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The use of mesoridazine in geriatrics.
    Goldstein SE
    Curr Ther Res Clin Exp; 1974 Apr; 16(4):316-23. PubMed ID: 4208348
    [No Abstract]   [Full Text] [Related]  

  • 30. Thiothixene in the treatment of mixed anxiety and depression.
    Goldstein BJ; Brauzer B
    J Clin Pharmacol New Drugs; 1973 Apr; 13(4):167-73. PubMed ID: 4570993
    [No Abstract]   [Full Text] [Related]  

  • 31. [Efficacy and tolerance of long-term naftidrofuryl treatment of patients with senile dementia. Controlled study versus placebo].
    Cucinotta D; Dall'Asta D; Benaglia F; Ciotti G; Nicora M; Passeri M
    G Clin Med; 1987 Apr; 68(4):211-7. PubMed ID: 3301493
    [No Abstract]   [Full Text] [Related]  

  • 32. Once versus thrice daily thiothixene in the treatment of schizophrenic in-patients.
    Lee JH; Branchey M; Haher EJ; Varga E; Simpson GM
    Br J Psychiatry; 1974 Jul; 125(0):73-8. PubMed ID: 4604854
    [No Abstract]   [Full Text] [Related]  

  • 33. A preliminary attempt to relate individual differences in EEG test dose response to clinical effect.
    May PR; Itil T; Van Putten T; Lee MA; Yale C
    Biol Psychiatry; 1982 May; 17(5):599-603. PubMed ID: 7093395
    [No Abstract]   [Full Text] [Related]  

  • 34. Haloperidol for chronically hospitalized psychotics: a double-blind comparison with thiothixene and placebo; a follow-up open evaluation.
    Howard JS
    Dis Nerv Syst; 1974 Oct; 35(10):458-63. PubMed ID: 17894059
    [No Abstract]   [Full Text] [Related]  

  • 35. Auditory attention in process and reactive schizophrenia.
    Maloney MP; Sloane RB; Whipple K; Rzani J; Eaton EM
    Biol Psychiatry; 1976 Jun; 11(3):325-32. PubMed ID: 779856
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment-resistant schizophrenia: controlled study of moderate- and high-dose thiothixene.
    Huang CC; Gerhardstein RP; Kim DY; Hollister L
    Int Clin Psychopharmacol; 1987 Jan; 2(1):69-75. PubMed ID: 3312398
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical evaluation of SKF-14336 in the treatment of psychosis associated with organic brain syndrome.
    Goldstein BJ; Jacobson S
    Dis Nerv Syst; 1969 Jan; 30(1):37-41. PubMed ID: 4887216
    [No Abstract]   [Full Text] [Related]  

  • 38. Management of behavioral symptoms in disturbed elderly patients: comparison of trifluoperazine and haloperidol.
    Lovett WC; Stokes DK; Taylor LB; Young ML; Free SM; Phelan DG
    J Clin Psychiatry; 1987 Jun; 48(6):234-6. PubMed ID: 3294815
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thiothixene in chronic schizophrenia. A clinical trial.
    Yilmaz AH
    Hawaii Med J; 1971; 30(3):178-82. PubMed ID: 4935845
    [No Abstract]   [Full Text] [Related]  

  • 40. Electrocardiographic evaluation of thiothixene: a double-blind comparison with thioridazine.
    Dillenkoffer RL; George RB; Bishop MP; Gallant DM
    Adv Biochem Psychopharmacol; 1974; 9(0):487-95. PubMed ID: 4599436
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.